The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation

by Seiichiro Tada, MD, Takayuki Anazawa, MD, PhD, Takero Shindo, MD, PhD, Kei Yamane, MD, Kenta Inoguchi, MD, Nanae Fujimoto, MSc, Kazuyuki Nagai, MD, PhD, Toshihiko Masui, MD, PhD, Hideaki Okajima, MD, PhD, Kyoichi Takaori, MD, PhD, Shoichiro Sumi, MD, PhD, Shinji Uemoto, MD, PhD
Published 2020-09-01